Back
CASI Pharmaceuticals 10K Form
Buy
61
CASI
CASI Pharmaceuticals
Last Price:
5.83
Seasonality Move:
11.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CASI News And Ratings
See the #1 stock for the next 7 days that we like better than CASI
CASI Financial Statistics
Sales & Book Value
Annual Sales: | $33.88M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $0.62 |
Price / Book: | 10.51 |
Profitability
EPS (TTM): | -2.04000 |
---|---|
Net Income (TTM): | $-27.18M |
Gross Margin: | $20.05M |
Return on Equity: | -88.87% |
Return on Assets: | -40.37% |
CASI Pharmaceuticals Earnings Forecast
Key CASI Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 28 years for CASI is 59.19%.
- The Selling, General & Administrative Expenses for CASI have been equal to 123.49% of Gross Profit Margin.
- The Research & Development expenses have been 29.11% of Revenue.
- The Interest Expense is 2.30% of Operating Income.
- The Net Earning history of CASI is -79.51% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 15 years.
CASI Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CASI |
CUSIP: | 14757U |
Website: | casipharmaceuticals.com |
Debt
Debt-to-Equity Ratio: | 2.05 |
---|---|
Current Ratio: | 3.88 |
Quick Ratio: | 2.14 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CASI Technical Analysis vs Fundamental Analysis
Buy
61
CASI Pharmaceuticals (CASI)
is a Buy
Is CASI Pharmaceuticals a Buy or a Sell?
-
CASI Pharmaceuticals stock is rated a Buy
The current CASI Pharmaceuticals [CASI] share price is $6.12. The Score for CASI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.